Network origin in Sophia Park first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
20
| Subsidiary | Pharmaceuticals: Major | 20 |
X-Body, Inc.
 X-Body, Inc. BiotechnologyHealth Technology X-BODY, Inc. provides biotechnological research services. The company was founded on April 9, 2009 and is headquartered in Waltham, MA.
2
| Subsidiary | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sophia Park via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Director of Finance/CFO General Counsel Director/Board Member Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member President | |
| The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Founder General Counsel | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member President | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Personal Genome Diagnostics, Inc.
 Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | Biotechnology | Director/Board Member | |
| NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Abdera Therapeutics, Inc.
 Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Biotechnology | Chairman | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Sapienza University of Rome | College/University | Undergraduate Degree | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President | |
| Novartis Holding Japan KK | Director of Finance/CFO | ||
| EPIZYME, INC. | Biotechnology | Director of Finance/CFO | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Pfizer Foundation, Inc.
 The Pfizer Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., The Pfizer Foundation, Inc. is a company committed to transparency and disclosure of activities of public interest. The company is based in New York, NY. Pfizer is dedicated to discovering breakthrough treatments, including medicines and vaccines, to benefit patients worldwide. The company is focused on treating 225 million people with these breakthrough treatments by 2025. The company's areas of interest include funding for educational activities, health education, and scientific research. Additionally, Pfizer is exploring the potential of mRNA technology to fight viruses and is working to understand the differences between biologics and biosimilars, particularly in terms of cost. | Miscellaneous Commercial Services | Director/Board Member | |
XTuit Pharmaceuticals, Inc.
 XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| The University of Southampton | College/University | Doctorate Degree | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member | |
Battersea Biotech, LLC
 Battersea Biotech, LLC Pharmaceuticals: MajorHealth Technology Battersea Biotech, LLC manufactures pharmaceutical products for cancer treatment. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| DESIGN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| NKARTA, INC. | Biotechnology | Director/Board Member | |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Investment Managers | Chief Executive Officer | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
Simcha Therapeutics, Inc.
 Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Simcha Therapeutics, Inc. operates as a biopharmaceutical company that develops engineered interleukin therapy products. The company was founded by Aaron Ring in 2018 and is headquartered in New Haven, CT. | Pharmaceuticals: Major | Director/Board Member | |
Simcha Therapeutics Holding Co. LLC
 Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Simcha Therapeutics Holding Co. LLC is a biopharmaceutical company which engages in developing an engineered interleukin therapy. The company was founded in 2018 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Director/Board Member | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
AbbVie Bioresearch Center, Inc.
 AbbVie Bioresearch Center, Inc. BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Bioresearch Center, Inc. is a company that provides drug discovery, development sciences, and biologics research services. The company is based in Worcester, MA. | Biotechnology | Corporate Officer/Principal | |
| Eurofins Discovery Products France SAS | Corporate Officer/Principal |
Statistics
International
| United States | 44 |
| Canada | 3 |
| Italy | 2 |
| Japan | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 35 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 2 |
Operational
| Director/Board Member | 115 |
| Independent Dir/Board Member | 48 |
| Corporate Officer/Principal | 36 |
| Director of Finance/CFO | 18 |
| Chairman | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Carol Gallagher | 39 |
| Clarence Machado | 31 |
| Simeon George | 23 |
| Mark Alles | 20 |
| Garry Nicholson | 16 |
| Barbara Bodem | 16 |
| Steven Harr | 11 |
| Gavin Hirst | 11 |
| Bernard Cassidy | 10 |
| Adam Levy | 8 |
| Kimberly McCutcheon Jablonski | 8 |
| Kyri van Hoose | 8 |
| Paolo Tombesi | 7 |
| Ed Gemo | 6 |
| Naseem Zojwalla | 6 |
- Stock Market
- Insiders
- Sophia Park
- Company connections
